{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:19:19Z","timestamp":1776089959702,"version":"3.50.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127589","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T20:46:47Z","timestamp":1433191607000},"page":"e0127589","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Michael P.","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Lieffers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Belch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelie","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randeep","family":"Sangha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Robert","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickie E.","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"S Antoun","year":"2010","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"CM Prado","year":"2008","journal-title":"The lancet oncology"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"CM Prado","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"L Martin","year":"2013","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"MS Sabel","year":"2011","journal-title":"Annals of surgical oncology"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Antoun S, Lanoy E, Iacovelli R, Albiges-Sauvin L, Loriot Y, Merad-Taoufik M, et al. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer. 2013. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1002\/cncr.28218\" xlink:type=\"simple\">10.1002\/cncr.28218<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23801109<\/object-id>.","DOI":"10.1002\/cncr.28218"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/met.2010.0133","article-title":"Markers of inflammation are heritable and associated with subcutaneous and ectopic skeletal muscle adiposity in African ancestry families","volume":"9","author":"I Miljkovic","year":"2011","journal-title":"Metabolic syndrome and related disorders"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCO.0b013e328337d826","article-title":"Epidemiology of myosteatosis","volume":"13","author":"I Miljkovic","year":"2010","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"issue":"3","key":"ref9","first-page":"783","article-title":"Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases","volume":"95","author":"M Federico","year":"2000","journal-title":"Intergruppo Italiano Linfomi. Blood"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"M Pfreundschuh","year":"2008","journal-title":"The lancet oncology"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"R Marcus","year":"2005","journal-title":"Blood"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"M Pfreundschuh","year":"2011","journal-title":"The lancet oncology"},{"issue":"9873","key":"ref13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"MJ Rummel","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2011-09-380949","article-title":"The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL","volume":"119","author":"C Muller","year":"2012","journal-title":"Blood"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","article-title":"Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy","volume":"86","author":"S Riihijarvi","year":"2011","journal-title":"European journal of haematology"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.2011.059246","article-title":"Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response","volume":"97","author":"U Jager","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"LH Sehn","year":"2007","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Lanic H, Kraut-Tauzia J, Modzelewski R, Clatot F, Mareschal S, Picquenot JM, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leukemia &amp; lymphoma. 2013. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.3109\/10428194.2013.816421\" xlink:type=\"simple\">10.3109\/10428194.2013.816421<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">23781925<\/object-id>.","DOI":"10.3109\/10428194.2013.816421"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"W Shen","year":"2004","journal-title":"Journal of applied physiology"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"M Mourtzakis","year":"2008","journal-title":"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"BH Goodpaster","year":"2000","journal-title":"Journal of applied physiology"},{"key":"ref22","unstructured":"Williams BA, Mandrekar JN, Mandrekar SJ, Cha SS, Furth AF. Finding Optimal Cutpoints for Continuous Covariates with Binary and Time-to-Event Outcomes. Technical Report Series 2006 June 2006."},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"BD Cheson","year":"2007","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"P Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"9759","key":"ref25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial","volume":"377","author":"G Salles","year":"2011","journal-title":"Lancet"},{"issue":"27","key":"ref26","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"M Federico","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref27","first-page":"CD008909","article-title":"Anthracycline-containing regimens for treatment of follicular lymphoma in adults","volume":"7","author":"G Itchaki","year":"2013","journal-title":"The Cochrane database of systematic reviews"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T19:03:09Z","timestamp":1566759789000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127589"}},"subtitle":[],"editor":[{"given":"Gayle E.","family":"Woloschak","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127589","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}